歐洲新聞 English-Botox 肉毒桿菌行業(yè)分?jǐn)?shù)據(jù) 英語(yǔ) John_第1頁(yè)
歐洲新聞 English-Botox 肉毒桿菌行業(yè)分?jǐn)?shù)據(jù) 英語(yǔ) John_第2頁(yè)
歐洲新聞 English-Botox 肉毒桿菌行業(yè)分?jǐn)?shù)據(jù) 英語(yǔ) John_第3頁(yè)
歐洲新聞 English-Botox 肉毒桿菌行業(yè)分?jǐn)?shù)據(jù) 英語(yǔ) John_第4頁(yè)
歐洲新聞 English-Botox 肉毒桿菌行業(yè)分?jǐn)?shù)據(jù) 英語(yǔ) John_第5頁(yè)
全文預(yù)覽已結(jié)束

歐洲新聞 English-Botox 肉毒桿菌行業(yè)分?jǐn)?shù)據(jù) 英語(yǔ) John.docx 免費(fèi)下載

版權(quán)說(shuō)明:本文檔由用戶提供并上傳,收益歸屬內(nèi)容提供方,若內(nèi)容存在侵權(quán),請(qǐng)進(jìn)行舉報(bào)或認(rèn)領(lǐng)

文檔簡(jiǎn)介

QYResearch|market@|

EuropeanBotoxMarketForecastGrowthto€2513.2Millionby2031with9.8%CAGR

Geneva,Switzerland—January7,2025

EuropeanBotoxMarket

AccordingtoarecentreportbyQYResearch,IpsenhasbeenmakingstridesintheEuropeanBotoxmarketwithitsinnovativeapproachestotherapeuticapplications.InJanuary2024,IpsenpresentedtheresultsofitsAboLiShstudyatthe7thInternationalTOXINSconferenceinBerlin,Germany.ThestudyfocusedontheuseofDysport?(abobotulinumtoxinA)fortreatinglower-limbspasticity.Findingsrevealedthatinjectionguidancetechniques,suchasultrasoundorelectromyography,significantlyimprovedpatientoutcomes,withpatientsnearlythreetimesmorelikelytoachievetheirrehabilitationgoalscomparedtothosewhoreceivedunguidedinjections.However,thestudyalsohighlightedagapinclinicalpractices,asnearly25%ofclinicianswerenotusinginjectionguidancetechniques,emphasizingtheneedforstandardizationtoenhancepatientcare.

MerzPharma,anotherkeyplayerintheEuropeanBotoxmarket,hasbeenleveraginginnovativemarketingstrategiestoexpanditspresence.InDecember2024,MerzAesthetics,adivisionofMerzPharma,launchedthe"LaterHaters"campaigntopromoteitsXEOMIN?(incobotulinumtoxinA)product.Thecampaignencourageswomento"Xout"judgmentandembracetheirself-careroutinesunapologetically.Thisinitiativeaimstoempowerwomentofeelconfidentintheiraesthetictreatmentchoices,reinforcingapositivenarrativearoundself-careandpersonalappearance.Theseefforts,asnotedintheQYResearchreport,underlineMerzPharma'scommitmenttocombiningeffectiveproductdevelopmentwithimpactfulbrandinginthecompetitiveEuropeanBotoxmarket.

TheEuropeanmarketforBotoxwasestimatedtobeworth€1306.2millionin2024andisforecasttoareadjustedsizeof€2513.2millionby2031withaCAGRof9.8%duringtheforecastperiod2025-2031.

EuropeanBotoxMarketSize(€Million),2025-2031

EuropeanBotoxTop20PlayersRankingandMarketShare(Rankingisbasedontherevenueof2024,continuallyupdated)

·Allergan(AbbVie)–UnitedStates

·Ipsen–France

·RevanceTherapeutics–UnitedStates

·Medytox–SouthKorea

·DaewoongPharmaceutical–SouthKorea

·Hugel–SouthKorea

·Evolus–UnitedStates

·Croma-Pharma–Austria

·CandelaMedical–UnitedStates

·MerzPharma–Germany

·SinoBiopharmaceuticalLimited–China

·ShanghaiHaohaiBiologicalTechnology–China

·LGChem–SouthKorea

·LanzhouInstituteofBiologicalProducts–China

·PharmathenPharmaceuticals–Greece

·Nabota(DaewoongPharmaceutical)–SouthKorea

·BiotechMedicalCorporation–Australia

·ToskaniCosmetics–Spain

·TeoxaneLaboratories–Switzerland

·AnikaTherapeutics–UnitedStates

3.Botox,EuropeanMarketSize,SplitbyRegion

Botox,EuropeanMarketSize,SplitbyProductSegment

5.Botox,EuropeanMarketSize,SplitbyApplicationSegment

BasedonorincludesresearchfromQYResearch:GlobalandEuropeanBotoxMarketReport2025-2031

RelatedMarketReportsFromQYResearch

QYResearchReleasesComprehensiveMarketReportsontheBotoxMarket,asshowninthelinksbelow.Thesereportsprovideanin-depthanalysisofthecurrentmarketlandscape,keytrends,andfuturegrowthopportunities.

B

溫馨提示

  • 1. 本站所有資源如無(wú)特殊說(shuō)明,都需要本地電腦安裝OFFICE2007和PDF閱讀器。圖紙軟件為CAD,CAXA,PROE,UG,SolidWorks等.壓縮文件請(qǐng)下載最新的WinRAR軟件解壓。
  • 2. 本站的文檔不包含任何第三方提供的附件圖紙等,如果需要附件,請(qǐng)聯(lián)系上傳者。文件的所有權(quán)益歸上傳用戶所有。
  • 3. 本站RAR壓縮包中若帶圖紙,網(wǎng)頁(yè)內(nèi)容里面會(huì)有圖紙預(yù)覽,若沒(méi)有圖紙預(yù)覽就沒(méi)有圖紙。
  • 4. 未經(jīng)權(quán)益所有人同意不得將文件中的內(nèi)容挪作商業(yè)或盈利用途。
  • 5. 人人文庫(kù)網(wǎng)僅提供信息存儲(chǔ)空間,僅對(duì)用戶上傳內(nèi)容的表現(xiàn)方式做保護(hù)處理,對(duì)用戶上傳分享的文檔內(nèi)容本身不做任何修改或編輯,并不能對(duì)任何下載內(nèi)容負(fù)責(zé)。
  • 6. 下載文件中如有侵權(quán)或不適當(dāng)內(nèi)容,請(qǐng)與我們聯(lián)系,我們立即糾正。
  • 7. 本站不保證下載資源的準(zhǔn)確性、安全性和完整性, 同時(shí)也不承擔(dān)用戶因使用這些下載資源對(duì)自己和他人造成任何形式的傷害或損失。

最新文檔

評(píng)論

0/150

提交評(píng)論